MENLO PARK, Calif., Dec. 8, 2011 /PRNewswire/ -- Sean P. David, M.D., Ph.D., SRI research physician and director of the Translational Medicine program in SRI’s Policy Division, has been selected as the 2011-2013 James C. Puffer, M.D./American Board of Family Medicine Fellow at the Institute of Medicine. David was selected from an outstanding group of nominees because of his accomplishments in family medicine, and specifically his work on smoking cessation and health promotion. In addition to his role at SRI, David is Clinical Associate Professor of Family and Community Medicine at Stanford University School of Medicine.
As part of the two-year fellowship, David is working with eminent researchers, policy experts, and clinicians from across the country to provide nonpartisan, evidence-based guidance to national, state, and local policymakers, academic leaders, health care administrators, and the public.
At SRI, David develops innovative patient-centered treatment methods for smoking cessation. A recent project was coordination between SRI and 49 other organizations working on the first genome-wide meta-analysis of smoking behaviors in African Americans.
David’s earlier experience includes leadership of several pharmacogenetic clinical trials of bupropion and nicotine replacement therapy and functional neuroimaging studies of nicotine dependence. He has authored more than 50 publications, mainly on smoking cessation, genetics, genomics, and public health, and is a co-leader of the STOMP (Study of Tobacco Use in Minority Populations) Genetics Consortium.
David received an M.D. at the University of Washington, and a Ph.D. in pharmacology from the University of Oxford. His residency training was at the New Hampshire/Dartmouth Family Medicine Residency Program, where he was chief resident and developed and led several health promotion programs with the C. Everett Koop Institute at Dartmouth.
Named in honor of James C. Puffer, president and chief executive officer of the American Board of Family Medicine, the fellowship program enables talented, early career health policy and science scholars in family medicine to participate in the work of IOM and further their careers as future leaders in the field.
About SRI International
Silicon Valley-based SRI International, a nonprofit research and development organization, performs sponsored R&D for governments, businesses, and foundations. SRI brings its innovations to the marketplace through technology licensing, new products, and spin-off ventures. Commemorating its 65th anniversary in 2011, SRI is known for world-changing innovations in computing, health and pharmaceuticals, chemistry and materials, sensing, energy, education, national defense, and more.
SOURCE SRI International
